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Clinical practice guidelines recommend annual screening for neuropathy for all
people with diabetes. Rapid and reliable sensory tests appropriate for the diagnosis
of neuropathy in Type 1 (T1) and Type 2 diabetes – which have been shown to
be predictors of foot complications – are established in routine diabetes practice.
As yet the reliability of these tests in Cystic Fibrosis related diabetes (CFRD) is
unknown. These sensory tests are not speciﬁc for diabetes neuropathy and may be
affected by factors relevant to CF such as age, height and exposure to neurotoxic
agents. The object of this study was to determine and explore any differences in
the results of three simple sensory tests to establish validity when screening for
neuropathy in patients with CFRD.
Research design and Methods: Three simple sensory tests were performed: the
10-g Semmes-Weisnstein monoﬁlament examination (SMWE), superﬁcial pain
sensation (SP) and vibration perception threshold (VPT) in 4 groups each of 30
subjects: CF patients, CFRD patients, T1 patients, and normal controls.
Results: The groups were sex and age matched (p = 0.26) with matching of the
diabetic groups for disease duration (T1 11.3 years, CFRD 10.1years). There was
no signiﬁcant difference between the groups for SMWE or VP. The control groups
showed a tendency to higher values for SP when compared to CFRD patients
(p = 0.066), however this was the least reproducible test. There were no differences
between CF patients and controls for any of the tests
Conclusion: The lack of a signiﬁcant difference between the CF group and controls
in all three tests suggests that abnormalities detected on the tests would be likely
due to speciﬁc pathological processes rather than an inherent feature of CF.
